Figure 2.
Cumulative incidence of acute GVHD in patients who underwent T cell–replete NIMA-complementary stem cell transplantation. Cumulative incidence curves of grades II-IV (A) and III-IV (B) acute GVHD according to the type of GVH target among 34 evaluable patients who received NIMA-complementary SCT. Solid lines represent SCT from mother to offspring (GVH target: IPA), while dashed lines indicate SCT from offspring or NIMA-mismatched siblings (GVH target: NIMA).

Cumulative incidence of acute GVHD in patients who underwent T cell–replete NIMA-complementary stem cell transplantation. Cumulative incidence curves of grades II-IV (A) and III-IV (B) acute GVHD according to the type of GVH target among 34 evaluable patients who received NIMA-complementary SCT. Solid lines represent SCT from mother to offspring (GVH target: IPA), while dashed lines indicate SCT from offspring or NIMA-mismatched siblings (GVH target: NIMA).

Close Modal

or Create an Account

Close Modal
Close Modal